tirzepatide type 2 diabetes monotherapy in Chinese patients with early diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO) ADA 2025: Advances in Type
Pay in 4 interest-free payments of $5.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28



























